X4 Pharmaceuticals (XFOR) Interest & Investment Income (2017 - 2025)
X4 Pharmaceuticals posted quarterly Interest & Investment Income of $2.0 million for Q4 2025, up 56.67% year-on-year from $1.3 million in Q4 2024, and up 120.31% on a QoQ basis from $901000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) has 9 years of Interest & Investment Income data on file, last reported at $2.0 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 56.67% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (down 20.68% YoY), and the FY2025 full-year result was $4.6 million, down 20.68% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $2.0 million, up from $901000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q4 2025 and bottomed at $2000.0 in Q1 2021.
- The 5-year median for Interest & Investment Income is $868000.0 (2023), against an average of $757800.0.
- The widest annual swing landed in 2021, when Interest & Investment Income tumbled 99.32%; it then surged 27733.33% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $3000.0 in 2021, then jumped by 6500.0% to $198000.0 in 2022, then surged by 629.8% to $1.4 million in 2023, then decreased by 12.32% to $1.3 million in 2024, then jumped by 56.67% to $2.0 million in 2025.
- The last three Interest & Investment Income figures came in at $2.0 million (Q4 2025), $901000.0 (Q3 2025), and $665000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 901,000.00 |
| Jun 30, 2025 | 665,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 914,000.00 |
| Mar 31, 2023 | 835,000.00 |
| Dec 31, 2022 | 198,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 296,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2019 | 464,000.00 |
| Jun 30, 2019 | 394,000.00 |
| Mar 31, 2019 | 69,000.00 |
| Dec 31, 2018 | 49,000.00 |
| Sep 30, 2018 | 51,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Mar 31, 2018 | 69,000.00 |
| Dec 31, 2017 | -26,000.00 |
| Sep 30, 2017 | 90,000.00 |